𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The roles of p53 and p21 in normal development and hyperthermia-induced malformations

✍ Scribed by Hiromi Hosako; Liezl E. Francisco; Gail S. Martin; Philip E. Mirkes


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
119 KB
Volume
86
Category
Article
ISSN
1542-9733

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND: Hyperthermia (HS) is a well‐studied teratogen that induces serious malformations, including neural tube defects. Our previous studies have shown that HS induces apoptosis by activating the mitochondrial apoptotic pathway. Prior to activation of the mitochondrial apoptotic pathway, HS also activates p53 and its target genes. In the present study, we determine whether p53 and/or p21 play a role as teratogen suppressors or inducers of HS‐induced malformations. METHODS: Pregnant mice carrying all three p53 or p21 genotype embryos were exposed to HS on day 8.5. Subsequently, fetuses were collected on day 15.5, and genotyped. In addition to genotype, we also determined the number of resorptions and dead fetuses as well as the number and types of external malformations. RESULTS: In the absence of HS exposure, fetuses exhibiting exencephaly and spina bifida were observed in approximately 11% of p53 −/− fetuses, whereas no malformations were observed among p21 −/− fetuses. Exposure to HS resulted in an increase in exencephaly and polydactyly in fetuses of all three p53 genotypes. However, the incidence of these malformations was statistically significantly higher in p53 −/− compared to p53 +/− and p53 +/+ fetuses. Exencephaly was the only malformation observed in p21 fetuses exposed to HS, with an approximately 2‐fold increase among p21 +/− and a 3‐fold increase among p21 −/− compared to p21 +/+ fetuses. CONCLUSIONS: Our study confirms that p53 plays a role in normal development and has shown, for the first time that p53 and p21 function to suppress HS‐induced malformations. Birth Defects Res (Part B) 86:40‐47, 2009. © 2009 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Role of p53 and ATM in photodynamic ther
✍ Viola Heinzelmann-Schwarz; André Fedier; René Hornung; Heinrich Walt; Urs Haller 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

## Abstract ## Background and Objectives Photodynamic therapy (PDT) induces cell death through a laser light‐activated photosensitizer and is a treatment option for tumors resistant to radio‐ and chemo‐therapy. ## Study Design/Materials and Methods We investigated whether m‐THPC‐PDT induces cell

Contrasting roles of IL-12p40 and IL-12p
✍ Luisa Camoglio; Nicole P. Juffermans; Maikel Peppelenbosch; Anje A. te Velde; Fi 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

IL-12(p70), a heterodimer composed of two subunits (p35 and p40), is a key cytokine for Th1 mediated inflammatory responses. We dissected the role of IL-12 in the development of 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis by studying mice deficient in IL-12p40, IL-12p35, or IL-12R g 1

Pharmacogenomics of the p53 tumor suppre
✍ Suxing Liu; W. Robert Bishop; Bimal Dasmahapatra; Yaolin Wang 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB 👁 1 views

## Abstract Drug resistance remains a key obstacle to successful cancer treatment. The implementation of pharmacogenomics is widely proclaimed as a route to revolutionize the face of cancer therapy. Here we discuss the pharmacogenomics of the p53 tumor suppressor and its role in cancer chemosensiti